Form 8-K - Current report:
SEC Accession No. 0000950170-24-130593
Filing Date
2024-11-25
Accepted
2024-11-25 16:30:07
Documents
11
Period of Report
2024-11-22
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 8-K meip-20241122.htm   iXBRL 8-K 40312
  Complete submission text file 0000950170-24-130593.txt   153846

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT meip-20241122.xsd EX-101.SCH 24867
13 EXTRACTED XBRL INSTANCE DOCUMENT meip-20241122_htm.xml XML 4705
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41827 | Film No.: 241496319
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)